A multi-organ lysosomal disorder where kidneys, muscles, thyroid, and swallowing all shape what weight management looks like
Cystinosis is a rare lysosomal storage disorder caused by mutations in the CTNS gene, which encodes cystinosin — the transporter that moves the amino acid cystine out of lysosomes. Without it, cystine accumulates inside lysosomes throughout the body, forming crystals that progressively damage virtually every organ system: kidneys, eyes (corneal crystals), muscles, thyroid gland, pancreas, liver, and the brain. It is the most common inherited cause of Fanconi syndrome (a defect of renal tubular reabsorption) in children.
Weight management in cystinosis is complex because the disease attacks so many of the systems that control energy balance — the kidneys that regulate fluid and electrolytes, the muscles that burn calories through movement, the thyroid gland that sets the metabolic rate, and increasingly in adults, the swallowing mechanism that determines what can be eaten at all. This article explains the multi-system picture and how to approach body weight safely alongside cysteamine therapy.
In nephropathic cystinosis, the renal proximal tubules lose their ability to reabsorb glucose, amino acids, phosphate, bicarbonate, potassium, sodium, and carnitine. This causes:
Many patients with nephropathic cystinosis undergo kidney transplantation by their teens or twenties. Transplantation does not cure the systemic cystine accumulation — cysteamine must be continued lifelong post-transplant. Post-transplant immunosuppression (tacrolimus, prednisolone) can cause weight gain, glucose intolerance, and metabolic syndrome, adding a new layer of weight management complexity.
In older patients and adults, cystine crystals accumulate in muscle fibres, causing progressive myopathy. This manifests as difficulty swallowing (dysphagia), proximal muscle weakness (difficulty rising from a chair, climbing stairs), and reduced exercise capacity. Muscle wasting reduces resting metabolic rate and makes conventional exercise progressively harder.
Thyroid gland cystine accumulation causes hypothyroidism in a significant proportion of older cystinosis patients. Hypothyroidism reduces metabolic rate, promotes weight gain, causes fatigue, and worsens cold sensitivity. Thyroid function should be checked regularly and levothyroxine prescribed as needed.
In some adults with cystinosis, pancreatic exocrine and endocrine function deteriorates — leading to fat malabsorption and insulin-dependent diabetes. These add further complexity to calorie absorption and blood sugar management.
Cysteamine (Cystagon capsules or Procysbi extended-release) is the only disease-modifying drug for cystinosis. It enters lysosomes and reacts with cystine to form a mixed disulfide that exits via a different transporter, preventing crystal accumulation. It does not reverse existing damage but dramatically slows new organ involvement when started early. It is taken every 6 hours (Cystagon) or every 12 hours (Procysbi).
Cysteamine causes nausea and gastrointestinal discomfort, especially early in therapy. Taking it with food reduces nausea but may slightly reduce absorption. Your specialist will guide optimal timing. This nausea can reduce appetite and food intake, potentially contributing to undernutrition.
Cysteamine eye drops are a separate treatment for corneal crystal dissolution and do not affect systemic cystine levels.
| Patient group | Primary weight concern | Main priority |
|---|---|---|
| Children (pre-transplant) | Underweight, growth failure | Maximise caloric density; correct electrolytes; optimise cysteamine |
| Adolescents/young adults (pre-transplant) | Variable; lean or normal weight common | Adequate protein and energy; support muscle maintenance |
| Adults post-transplant on immunosuppression | Overweight; steroid-related weight gain; metabolic syndrome | Caloric control; low refined carbohydrate; regular exercise |
| Adults with myopathy/dysphagia | Underweight due to swallowing difficulty | Texture-modified diet; energy-dense soft foods; speech therapy |
| Adults with hypothyroidism | Overweight due to low metabolic rate | Treat hypothyroidism first; then modest caloric deficit |
Adequate protein is essential to counteract amino acid urinary losses and maintain muscle mass. Protein restriction is rarely indicated in cystinosis (unlike some other metabolic conditions) unless late-stage kidney disease makes it necessary. Target 1.2-1.5 g/kg/day of high-quality protein. However, very high protein intakes can increase the metabolic acid load, stressing a kidney already struggling with Fanconi syndrome — avoid high-protein fad diets.
Because urinary phosphate wasting is severe, dietary phosphate intake is important. Dairy, legumes, nuts, and whole grains are good sources. However, phosphate supplements are still usually required — food alone cannot compensate for renal losses.
Carnitine is lost in the urine in Fanconi syndrome. Secondary carnitine deficiency impairs fat oxidation. L-carnitine supplementation (as prescribed by your physician) is important for energy metabolism and muscle function — similar to the role it plays in Primary Carnitine Deficiency.
A common question is whether reducing dietary cystine (found in high-protein foods) helps reduce cystine accumulation. The answer is no — lysosomal cystine comes from protein recycling within cells, not primarily from dietary intake. Reducing dietary cystine does not meaningfully reduce lysosomal accumulation. Cysteamine therapy, not dietary cystine restriction, is the treatment.
Post-transplant patients on immunosuppression often need to:
| Useful foods in cystinosis | Notes |
|---|---|
| Lean chicken, fish (hake, pilchards), eggs | Good protein with manageable phosphate; soft texture for dysphagia patients |
| Amasi (maas), low-fat dairy | Phosphate source; protein; comfortable texture |
| Mashed sweet potato, pap, soft maize dishes | Energy-dense, easy to swallow, potassium source |
| Lentils and sugar beans (soft-cooked) | Protein + phosphate + fibre; good post-transplant option |
| Rooibos tea | Antioxidant; kidney-supportive; hydrating |
| Bananas, avocado (in moderation) | Potassium replacement; energy-dense for underweight patients |
| Fortified cereals (soft) | B vitamins; phosphate; easy to eat with dysphagia |
Cystinosis myopathy affecting the swallowing muscles is a well-recognised late complication. If you notice difficulty swallowing solid foods, choking, or food sticking in the throat, this is medically significant — not just an annoyance:
Exercise is important but must be adapted:
Cystinosis requires lifelong multi-specialist monitoring:
In South Africa, nephropathic cystinosis is managed at Red Cross War Memorial Children's Hospital (Cape Town), Charlotte Maxeke Johannesburg Academic Hospital, and Steve Biko Academic Hospital (Pretoria). Adults need transition to nephrology and internal medicine services with metabolic experience. Rare Diseases South Africa (rarediseases.org.za) provides patient support.